Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
British Journal of Haematology
|
November 19, 2025
Repurposing pacritinib to target MYD88-mutated Waldenström macroglobulinaemia
Shirong Liu, Amanda Kofides, Xia Liu, et al.
Journal of Medical Virology
|
January 18, 2024
Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis
Shanghao Liu, Jianzhong Ma, Ping Chen, et al.
Nature Communications
|
December 9, 2015
Identification and characterization of latency-associated peptide-expressing γδ T cells
Rafael M Rezende, Andre P da Cunha, Chantal Kuhn, et al.
Blood Advances
|
January 16, 2026
Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom Macroglobulinemia
Nickolas Tsakmaklis, Zachary R Hunter, Xia Liu, et al.
The Science of the Total Environment
|
July 30, 2020
Mapping forest type and age in China's plantations
Zhen Yu, Hongrun Zhao, Shirong Liu, et al.
Blood
|
November 16, 2023
Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia
Jorge J Castillo, Andrew R Branagan, David Sermer, et al.
Blood Advances
|
January 18, 2024
Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia
Kris Richardson, Jorge J Castillo, Shayna R Sarosiek, et al.
Microbiome
|
February 23, 2023
Gamma-delta T cells modulate the microbiota and fecal micro-RNAs to maintain mucosal tolerance
Rafael M Rezende, Laura M Cox, Thais G Moreira, et al.
Annals of Neurology
|
April 20, 2021
Gut Microbiome in Progressive Multiple Sclerosis
Laura M Cox, Amir Hadi Maghzi, Shirong Liu, et al.
Blood Advances
|
April 15, 2026
Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells
Dominic Pizzarella, Amanda Kofides, John M Hatcher, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
British Journal of Haematology
|
November 19, 2025
Repurposing pacritinib to target MYD88-mutated Waldenström macroglobulinaemia
Shirong Liu, Amanda Kofides, Xia Liu, et al.
Journal of Medical Virology
|
January 18, 2024
Novel serum biomarker of Golgi protein 73 for the diagnosis of clinically significant portal hypertension in patients with compensated cirrhosis
Shanghao Liu, Jianzhong Ma, Ping Chen, et al.
Nature Communications
|
December 9, 2015
Identification and characterization of latency-associated peptide-expressing γδ T cells
Rafael M Rezende, Andre P da Cunha, Chantal Kuhn, et al.
Blood Advances
|
January 16, 2026
Quantitative MYD88L265P and CXCR4S338X analysis to assess clinical trial performance in Waldenstrom Macroglobulinemia
Nickolas Tsakmaklis, Zachary R Hunter, Xia Liu, et al.
The Science of the Total Environment
|
July 30, 2020
Mapping forest type and age in China's plantations
Zhen Yu, Hongrun Zhao, Shirong Liu, et al.
Blood
|
November 16, 2023
Ibrutinib and venetoclax as primary therapy in symptomatic, treatment-naïve Waldenström macroglobulinemia
Jorge J Castillo, Andrew R Branagan, David Sermer, et al.
Blood Advances
|
January 18, 2024
Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia
Kris Richardson, Jorge J Castillo, Shayna R Sarosiek, et al.
Microbiome
|
February 23, 2023
Gamma-delta T cells modulate the microbiota and fecal micro-RNAs to maintain mucosal tolerance
Rafael M Rezende, Laura M Cox, Thais G Moreira, et al.
Annals of Neurology
|
April 20, 2021
Gut Microbiome in Progressive Multiple Sclerosis
Laura M Cox, Amir Hadi Maghzi, Shirong Liu, et al.
Blood Advances
|
April 15, 2026
Zanubrutinib and pirtobrutinib show synergistic killing and suppression of BTK signaling in MYD88-mutated lymphoma cells
Dominic Pizzarella, Amanda Kofides, John M Hatcher, et al.
Page
of 15